ClinicalTrials.govpublic full text
Study on the Effect of Oral Diammonium Glycyrrhizinate in Attenuating Toxicity and Enhancing Efficacy of CAR-T Cell Therapy
patients with large b-cell lymphoma receiving car-t cell therapy, large b-cell lymphoma, diammonium glycyrrhizinate, car-t cell therapy, toxicity reducing and efficacy enhancing, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 844493
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.